Showing results (601-610 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|December 23, 1998
Results of transrectal ultrasound-guided biopsies and clinical significance of Japanese prostate cancerS Egawa, K Matsumoto, K Yoshida, et al.
Japanese Journal of Clinical Oncology|December 20, 2007
Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacityYukihiro Yoshida, Akiko Kokubu, Kenji Suzuki, et al.
Japanese Journal of Clinical Oncology|February 16, 2006
Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposisMichihiro Mutoh, Takayuki Akasu, Mami Takahashi, et al.
Japanese Journal of Clinical Oncology|February 16, 2006
Extended right hemihepatectomy as a salvage operation for recurrent bile duct cancer 3 years after pancreatoduodenectomyTaizo Hibi, Yoshihiro Sakamoto, Naobumi Tochigi, et al.
Japanese Journal of Clinical Oncology|February 16, 2006
MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancerJi Woong Sohn, Shin Yup Lee, Su Jung Lee, et al.
Japanese Journal of Clinical Oncology|February 1, 1991
A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancerK Yamada, N Saijo, A Kojima, et al.
Japanese Journal of Clinical Oncology|February 1, 1991
Changes in mode of response to chemotherapy for hepatocellular carcinoma induced by transarterial embolization. A case reportN Okazaki, T Yoshida, M Yoshino, et al.
Japanese Journal of Clinical Oncology|February 1, 1991
Human papillomavirus type 31 DNA detected in part of the dysplasia but in no part of the squamous metaplasia in a specimen taken from one patientS Shimano, M Fukushima, A Nishikawa, et al.
Japanese Journal of Clinical Oncology|May 30, 2008
Are three additional cycles of chemotherapy useful in patients with advanced-stage epithelial ovarian cancer after a complete response to six cycles of intravenous adjuvant paclitaxel and carboplatin?Hee Seung Kim, Noh-Hyun Park, Hyun Hoon Chung, et al.
Japanese Journal of Clinical Oncology|October 9, 2009
Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trialWasaburo Koizumi, Toshikazu Akiya, Atsushi Sato, et al.
Pageof 534